What's breaking now, across thousands of outlets.
Definium Therapeutics reported results Monday for its third Phase 3 readout this year on its oral LSD candidate, called DT120, and is gearing up for an FDA submission. The company’s late-stage data are from a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The research team sent 135 unpackaged artificial lenses to the International Space Station, where they spent around six months exposed to conditions in low-Earth orbit before returning to Earth for…
Great links, images, and reading from Chartbook Newsletter by Adam Tooze
In Pennsylvania, a 40-year-old woman has died from measles complications, becoming the third fatality this year amid the state's significant outbreak.
Meet Muthuri Kinyamu, the Nairobi entrepreneur whose fleet of wheelchair-accessible vehicles, BLS-trained driver-guides and disability-etiquette-trained staff is quietly transforming how Kenya's…
Hayden Panettiere died from an apparent overdose after consuming a lethal pill, suspected to contain oxycodone and fentanyl.
AstraZeneca said Friday that its recently approved breast cancer drug Etcamah failed a late-stage trial designed to support a label expansion into an earlier setting.
